and centralized laboratory testing for clinical assessment and commercialization—Bio-Techne has the experience and expertise to offer a seamless translational biomarker development program ...
Advances in the molecular definition of disease, biomarker technologies and informatics have brought us to the threshold of a new way to individualize treatment for patients - personalized medicine.
https://www.tipranks.com/news/the-fly/option-care-health-price-target-raised-to-35-from-30-at-jmp-securities Seres Therapeutics (MCRB) announced new translational ...
(Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics company, today announced new translational biomarker results for exploratory endpoints from its SER-155 Phase 1b placebo ...
I am a bioinformatician working in the Cancer Biomarkers and Translational Therapeutics Teams at the Institute of Cancer Research. I work with next generation sequencing data to understand prostate ...
Because biomarkers for precision medicine and translational research are often nucleic acid based, DNA and RNA detection methods and technologies are at the forefront of this progress. Experts from ...
Seres Therapeutics (MCRB) announced new translational biomarker results for exploratory endpoints from its SER-155 Phase 1b placebo-controlled study in patients undergoing allogenic stem cell ...
CAMBRIDGE, Mass., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics company, today announced new translational biomarker ...
NEW YORK--(BUSINESS WIRE)--Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today a publication in Clinical and Translational Science, titled ...